Gene Discovery May Shed Light On Kidney Diseases; Second Gene Found For Alagille Syndrome May Have Broader Role
The researchers found that mutations in the NOTCH2 gene were linked to kidney abnormalities in patients and families. \"While Alagille syndrome is relatively rare, organ diseases are not rare, and our findings suggest that genes on this biological pathway may have a broader role in kidney disorders,\" said study leader Nancy B. Spinner, Ph.D., a geneticist at The Children\'s Hospital of Philadelphia.
The study appears in the July issue of the American Journal of Human Genetics.
Dr. Spinner led the Children\'s Hospital team that identified mutations in the JAG1 gene as a cause of Alagille syndrome in 1997. Like the NOTCH2 gene analyzed in the current study, JAG1 is part of a signaling pathway that governs important processes in early human development.
Alagille syndrome, estimated to occur in one in 20,000 individuals, is a complex disorder, primarily affecting the liver, heart, eyes, face and skeleton. Some patients with Alagille syndrome have very mild symptoms or isolated problems, while others may have severe, life-threatening heart or liver defects.
Both the JAG1 and the NOTCH2 genes participate in the Notch signaling pathway. JAG1 codes for the ligand Jagged1, a signaling protein that triggers receptors in the pathway. The NOTCH2 gene codes for Notch2, which is one of those receptors. The pathway as a whole is active during embryonic development, and transmits signals to cells to develop into specialized organs. Mutations in those genes are thought to disrupt normal development, by, for instance, causing the defective bile ducts found in the livers of many patients with Alagille syndrome.
\"Ligands and receptors are like keys and locks,\" said Dr. Spinner. \"If either one is defective, it may interfere with normal growth and development.\"
Dr. Spinner\'s team previously determined that 94 percent of patients diagnosed with Alagille syndrome had mutations in the JAG1 gene. In the current study, they analyzed 11 patients with Alagille syndrome who did not have the JAG1 mutation, and found that two of them had mutations in NOTCH2. Furthermore, the patients had three family members, all mildly affected, who also had the same mutation. All five individuals had kidney disease.
Because their study identified only two families with NOTCH2 mutations, said Dr. Spinner, it is not definitive in establishing that those mutations cause a distinct variety of Alagille syndrome. However, it is the first study to report that mutations in the NOTCH2 gene cause human disease. Dr. Spinner is planning further studies to better characterize the role of NOTCH2 mutations and the Notch signaling pathway in the wider population of patients with kidney disorders.
She also will investigate liver involvement in Alagille syndrome under the Rare Diseases Clinical Research Network, recently established by the National Institutes of Health. \"Part of the rationale for this research network is that, collectively, relatively rare diseases added together constitute a significant portion of the population,\" said David A. Piccoli, M.D., chief of Gastroenterology and Nutrition at Children\'s Hospital and a co-author of the study. \"Another rationale is that studying relatively rare diseases may offer insights into more common diseases and into health in general.\"
The National Institute for Diabetes and Digestive Diseases supported this study, as did the Fred and Suzanne Biesecker Center at The Children\'s Hospital of Philadelphia. Co-authors with Drs. Spinner and Piccoli, all from Children\'s Hospital and the University of Pennsylvania School of Medicine, were Ian Krantz, M.D.; Ryan McDaniell, Daniel M. Warthen, Pedro A. Sanchez-Lara and Athma Pai.
About The Children\'s Hospital of Philadelphia: The Children\'s Hospital of Philadelphia was founded in 1855 as the nation\'s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children\'s Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
The Children\'s Hospital of Philadelphia
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Backing, Christopher. "Gene Discovery May Shed Light On Kidney Diseases; Second Gene Found For Alagille Syndrome May Have Broader Role." Medical News Today. MediLexicon, Intl., 1 Aug. 2006. Web.
22 Jun. 2017. <http://www.medicalnewstoday.com/releases/48392.php>
Backing, C. (2006, August 1). "Gene Discovery May Shed Light On Kidney Diseases; Second Gene Found For Alagille Syndrome May Have Broader Role." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.